1. Chen, E, Liu, NanJing, Zhao, Yan, Wu, XiaoHou, Luo, ChunLi. 2021. Panobinostat reverses HepaCAM gene expression and suppresses proliferation by increasing histone acetylation in prostate cancer. In Gene, 808, 145977. doi:10.1016/j.gene.2021.145977. https://pubmed.ncbi.nlm.nih.gov/34592353/
2. He, Yunfeng, Wu, Xiaohou, Luo, Chunli, Wang, Lie, Lin, Jie. 2010. Functional significance of the hepaCAM gene in bladder cancer. In BMC cancer, 10, 83. doi:10.1186/1471-2407-10-83. https://pubmed.ncbi.nlm.nih.gov/20205955/
3. Wang, Xiaorong, Chen, E, Yang, Xue, Wu, Xiaohou, Luo, Chunli. 2015. 5-azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene. In Oncology reports, 35, 1375-84. doi:10.3892/or.2015.4492. https://pubmed.ncbi.nlm.nih.gov/26677113/
4. Fan, Yanru, Ou, Liping, Fan, Jiaxin, Gao, Yingying, Niu, Lingfang. 2018. HepaCAM Regulates Warburg Effect of Renal Cell Carcinoma via HIF-1α/NF-κB Signaling Pathway. In Urology, 127, 61-67. doi:10.1016/j.urology.2018.11.033. https://pubmed.ncbi.nlm.nih.gov/30528714/
5. Shao, Huanzhang, Gu, Yinjie, Ding, Junli, Ruan, Tingyan, Lu, Wenbin. 2015. HEPACAM inhibited the growth and migration of cancer cells in the progression of non-small cell lung cancer. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 37, 2621-7. doi:10.1007/s13277-015-4084-9. https://pubmed.ncbi.nlm.nih.gov/26392113/